Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01532830 · ClinicalTrials.gov registry record · NA
Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine
A NA study of Migraine, sponsored by ElectroCore.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT01532830 is a NA study of Migraine that has completed, run by ElectroCore. The registered enrollment target is 30 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT01532830, a NA study of Migraine, has completed, sponsored by ElectroCore.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment and/or prevention of migraine symptoms.
Conditions Studied
Interventions
- DEVICE n-VNS
Study Locations (3)
New York
- New York Headache Center - New York
- Montefiore Headache Center - The Bronx
California
- UCSF Headache Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01532830
The ClinicalTrials.gov registry entry for NCT01532830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower). The listed sponsor is ElectroCore, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which n-VNS is the first listed.
NCT01532830 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, California.
Frequently Asked Questions
What is clinical trial NCT01532830 about?
NCT01532830 is a clinical study titled "Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine". The purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment and/or prevention of migraine symptoms.
What is the current status of trial NCT01532830?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-02. Estimated completion is 2012-07-25.
What conditions does trial NCT01532830 study?
This clinical trial studies the following conditions: Migraine.
What interventions are being tested in trial NCT01532830?
The interventions under investigation include: n-VNS (DEVICE).
Who is sponsoring clinical trial NCT01532830?
This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01532830 being conducted?
This trial has 3 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.